Start » Intra-operative ablations for atrial fibrillation

Atrial fibrillation

Normally, the healthy heart moves rhythmically at a rate of between 60 and 80 beats per minute. The heartbeat is controlled by the impulse generator in the area of the right atrium (sinus node) and leads to a regular movement (contraction) of the cardiac atria and the main chambers of the heart. In atrial fibrillation, there is an uncoordinated, arrhythmic sequence of events in the heart’s ventricles – a so-called “fibrillation”. The ventricles typically twitch 150 to 600 times per minute and are functionally at a standstill. This leads to an impaired onward transport of the blood into the main chambers. This can result in the following problems:

  1. Restriction of physical resilience with palpitations, malaise and shortness of breath
  2. Decrease in the heart’s performance
  3. 4 to 5-fold increased risk of developing a stroke due to blood clots being washed out into the brain vessels.

However, atrial fibrillation does not necessarily cause symptoms and can be asymptomatic (symptom-free) in a certain proportion of patients.

There are many causes for the development of atrial fibrillation. Known risk factors for atrial fibrillation include older age, high blood pressure, thyroid disease and other heart conditions. In particular, patients with long-standing valvular heart disease are often affected.

General therapy

Treatment focuses on relieving symptoms and minimising risks, such as the development of a stroke. This is done with medication in the early phase of the disease. Anticoagulant drugs (blood thinners) are used to prevent strokes. These cause an improvement in the flow properties of the blood and thus prevent the formation of blood clots in the atria. To restore a regular heartbeat, heart rate-lowering and rhythm-stabilising drugs (anti-arrhythmics) are used.

If the use of anti-arrhythmic drugs does not stabilise the heartbeat, surgical sclerotherapy of the heart muscle in the area of the atria may be necessary. Surgical treatment of atrial fibrillation is mainly carried out when other heart diseases requiring treatment are present at the same time.

Surgical therapy – MAZE operation

In the Department of Cardiovascular Surgery at the German Heart Centre Munich, the surgical treatment of atrial fibrillation is performed as an additional intervention within the framework of other cardiac surgery in the area of the heart valves (especially mitral valve diseases) or the coronary vessels.

Surgical treatment of atrial fibrillation is based on the principle of local sclerotherapy of heart muscle tissue (ablation). Here, heat (radiofrequency ablation) or cold application (cryoablation) is used to draw scar lines in the area of both atrioventricular chambers, which interrupt the spread of atrial fibrillation. The labyrinthine arrangement of these ablation lines makes it possible only for the normal excitation waves triggered by the sinus node to propagate. This restores a regular heartbeat. In addition to surgical ablation, the standard procedure is to remove the left atrial appendage (blind sac in the area of the left atrium) as the main source of blood clots. This significantly reduces the occurrence of strokes.

 

The success of surgical therapy depends primarily on the size and thickness of the atrial chambers and the duration of the atrial fibrillation. The success rate for regaining a regular heartbeat is on average between 50 and 80 per cent.